eeez
2021-10-22
Good
Enfusion rose over 20% after it opened at $20 above $17 IPO price
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
eeez
2021-10-22
eeez
👌
什么也没有了～
APP内打开
发表看法
2
6
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":853728290,"tweetId":"853728290","gmtCreate":1634852164939,"gmtModify":1634852164939,"author":{"id":3570813663502369,"authorId":3570813663502369,"authorIdStr":"3570813663502369","name":"eeez","avatar":"https://static.tigerbbs.com/3e4f974ced53f13a2b714d56018e7b43","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Good</p></body></html>","htmlText":"<html><head></head><body><p>Good</p></body></html>","text":"Good","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/853728290","repostId":1197098922,"repostType":4,"repost":{"id":"1197098922","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634830609,"share":"https://www.laohu8.com/m/news/1197098922?lang=&edition=full","pubTime":"2021-10-21 23:36","market":"us","language":"en","title":"Enfusion rose over 20% after it opened at $20 above $17 IPO price","url":"https://stock-news.laohu8.com/highlight/detail?id=1197098922","media":"Tiger Newspress","summary":"Enfusion rose over 20% after itopened at $20 above $17 IPO price.Enfusion is a global fast-growing ","content":"<p>Enfusion rose over 20% after itopened at $20 above $17 IPO price.<img src=\"https://static.tigerbbs.com/08aaed72748df105d8d6111aeadc2325\" tg-width=\"770\" tg-height=\"367\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Enfusion is a global fast-growing SaaS provider, focusing on the transformation of the investment management industry. The company aims to remove technical and information barriers and enable investment managers to confidently make and execute smarter investment decisions in real time. In 2019-2020, the company's revenues were US $59.03 million and US $79.57 million respectively, and the corresponding net profits were US $12.66 million and US $4.06 million respectively.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Enfusion rose over 20% after it opened at $20 above $17 IPO price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEnfusion rose over 20% after it opened at $20 above $17 IPO price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-21 23:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Enfusion rose over 20% after itopened at $20 above $17 IPO price.<img src=\"https://static.tigerbbs.com/08aaed72748df105d8d6111aeadc2325\" tg-width=\"770\" tg-height=\"367\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Enfusion is a global fast-growing SaaS provider, focusing on the transformation of the investment management industry. The company aims to remove technical and information barriers and enable investment managers to confidently make and execute smarter investment decisions in real time. In 2019-2020, the company's revenues were US $59.03 million and US $79.57 million respectively, and the corresponding net profits were US $12.66 million and US $4.06 million respectively.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ENFN":"Enfusion, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197098922","content_text":"Enfusion rose over 20% after itopened at $20 above $17 IPO price.Enfusion is a global fast-growing SaaS provider, focusing on the transformation of the investment management industry. The company aims to remove technical and information barriers and enable investment managers to confidently make and execute smarter investment decisions in real time. In 2019-2020, the company's revenues were US $59.03 million and US $79.57 million respectively, and the corresponding net profits were US $12.66 million and US $4.06 million respectively.","news_type":1},"isVote":1,"tweetType":1,"viewCount":179,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":6280655,"gmtCreate":1634855378575,"gmtModify":1634855378575,"authorId":3570813663502369,"author":{"id":3570813663502369,"authorId":3570813663502369,"name":"eeez","avatar":"https://static.tigerbbs.com/3e4f974ced53f13a2b714d56018e7b43","vip":1,"hat":"https://static.tigerbbs.com/f84859c65fc2d7681e28f6b8e9b0535a","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":853728290,"type":1,"supId":0,"prevId":0,"content":"👌","text":"👌","html":"👌","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/853728290"}
精彩评论